Europe Peritoneal Dialysis Market worth $2.72 billion by 2031
The Report "Europe Peritoneal Dialysis Market by Offering (Peritoneal Dialysis Solution Bags, Machines), Modality (Continuous Ambulatory Peritoneal Dialysis (CAPD)), Disease Indication (End-stage Renal Disease), End User (Hospitals) - Global Forecast to 2031" is projected to grow from USD 2.20 billion in 2026 and to reach USD 2.72 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period.
Browse 150 market data Tables and 50 Figures spread through 200 Pages and in-depth TOC on "Europe Peritoneal Dialysis Market by Offering (Peritoneal Dialysis Solution Bags, Machines), Modality (Continuous Ambulatory Peritoneal Dialysis (CAPD)), Disease Indication (End-stage Renal Disease), End User (Hospitals) - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/europe-peritoneal-dialysis-market-195660405.html
The increased prevalence of chronic kidney disease, growing preference for home-based dialysis, favorable reimbursement policies, and increasing acceptance of automated peritoneal dialysis (APD) systems that improve lifestyle and clinical outcomes collectively drive the peritoneal dialysis market in Europe. However, factors including uneven adoption of peritoneal dialysis across countries, limited patient and clinician awareness, a higher risk of infections such as peritonitis, and the requirement for extensive patient training impede the market's growth. Key market opportunities include the expansion of telehealth-enabled remote monitoring, government incentives that support home-based therapies, ongoing innovations in peritoneal dialysis devices, and a growing shift across Europe toward cost-effective home dialysis care over hospital-based treatment.
This report segments the peritoneal dialysis market by offering, modality, disease indication, end user, and country.
“Continuous ambulatory peritoneal dialysis (CAPD) segment accounted for largest share of the Europe peritoneal dialysis market, by Modality, in 2025.”
Continuous ambulatory peritoneal dialysis (CAPD) currently holds the largest market share in Europe for peritoneal dialysis, as it is a simple, cost-effective, and highly accessible modality with no requirements for automated equipment, making it suitable for a wide range of patients and healthcare configurations. CAPD offers more flexibility, requires minimal infrastructure, and has a lower initial cost than APD. Thus, such a modality can be adopted in developed and emerging regions in Europe. Its simplicity in training and self-administration also encourages patient independence and, therefore, less reliance on clinic-based support. Already established reimbursement schemes, along with the long-standing familiarity of clinicians with CAPD, further help extend its usage. Consequently, it guarantees to remain the most critical modality within the PD therapy landscape in the region.
“Peritoneal dialysis machines segment to record highest CAGR in Europe Peritoneal Dialysis market, by offering, during forecast period.”
In the Europe peritoneal dialysis market, PD machines are expected to register the highest CAGR due to the increasing adoption of automated peritoneal dialysis, which offers ease of use, overnight operation, and accurate, consistent therapy delivery. Advanced machines provide enhanced treatment settings that improve fluid management and overall patient comfort, supporting better clinical outcomes. The ongoing shift toward home-based dialysis across Europe, supported by favorable reimbursement policies and digital remote monitoring, is further driving demand for automated PD systems. Moreover, PD machines contribute significantly to market revenue due to their higher unit value compared to consumables, while continuous technological innovation, improved connectivity, and strong uptake among younger and working patients reinforce their leading market position.
“France to be fastest-growing market in Europe during forecast period.”
In the Europe peritoneal dialysis market, France is expected to record the highest CAGR due to a number of reinforcing factors. For instance, the country is actively promoting home dialysis programs, supported by reimbursement reforms favorable to the adoption of both CAPD and APD. Concurrently, France has an increasing prevalence of diabetes and hypertension, which is raising access to ESRD and demand for different forms of dialysis. The government focus on reducing in-center dialysis burden and enhancing patient quality of life is fast-tracking the uptake of PD. Further development includes a robust hospital infrastructure, increased utilization of telemonitoring tools, and higher levels of clinician training in PD catheter placement, all of which contribute to a fast-tracked adoption. All of these dynamics position France as the fastest-growing PD market in the region.
Key Market Players:
Key players in this market are adopting several organic and inorganic growth strategies (such as product launches, agreements, collaborations, acquisitions, and expansions). Prominent players in this market include Vantive Health LLC (US), Fresenius Medical Care AG (Germany), Medtronic plc (Ireland), Davita Inc. (US), Becton, Dickinson and Company (US), Utah Medical Products, Inc. (US), Terumo Corporation (Japan), Diaverum AB (Sweden), Medionics (Canada), Newsol Technologies (Canada), Apollo Dialysis Pvt Ltd (India), U.S. Renal Care, Inc. (US), Northwest Kidney Centers (US), Relavo (US), JMS Co., Ltd. (Japan), AMECATH (Egypt), Huaren Pharmaceutical (China), AWAK Technologies (Singapore), Innovative Renal Care (US), and Renax Biomedical Technology Co., Ltd (China).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Europe Peritoneal Dialysis Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
